Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding
2026-07-15
The reference study uncovers that naturally occurring angiotensin peptides, particularly truncated forms such as Angiotensin 1/2 (5-7), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings redefine the intersection of renin-angiotensin system biology and COVID-19 pathogenesis, highlighting new avenues for both cardiovascular and viral research.
Streptavidin-Cy3 in Next-Gen Biotin Detection and Biohybrid
2026-07-14
Explore the advanced roles of Streptavidin-Cy3 in high-resolution biotin detection and its unique implications for biohybrid microrobots and adaptive imaging. This article offers a deeper look at assay optimization and the latest innovations beyond conventional applications.
Cell Counting Kit-8: Sensitive Cell Proliferation & Viabilit
2026-07-14
Cell Counting Kit-8 (CCK-8) from APExBIO delivers highly sensitive, reproducible cell proliferation and cytotoxicity measurements with a user-friendly workflow for modern biomedical research. Explore workflow enhancements, troubleshooting insights, and practical integration with cartilage regeneration and OA intervention studies.
ML216, BLM Helicase Inhibitor: Precision Tools for DNA Repai
2026-07-13
ML216, a potent BLM helicase inhibitor from APExBIO, enables researchers to dissect DNA repair vulnerabilities and model synthetic lethality with exceptional selectivity and submicromolar potency. This article delivers actionable workflows, troubleshooting strategies, and translational perspectives for maximizing ML216’s impact in cancer biology.
GSK343: Precision EZH2 Inhibitor for Epigenetic Cancer Resea
2026-07-13
GSK343 stands out as a potent, selective EZH2 inhibitor empowering researchers to dissect histone H3K27 trimethylation and its impact on tumor immunogenicity. This guide delivers actionable protocols, troubleshooting strategies, and workflow enhancements for leveraging GSK343 in breast and prostate cancer research.
Phenothiazines Induce Macrophage ROS and Autophagy for Antib
2026-07-12
This study demonstrates that phenothiazines significantly boost the antibacterial function of macrophages by triggering reactive oxygen species (ROS) and autophagy. These findings highlight a promising host-directed therapeutic strategy to combat intracellular bacterial infections, especially in the context of increasing antimicrobial resistance.
Novel PDK4 Inhibitors: Advancing Metabolic Disease Therapeut
2026-07-10
This article reviews a recent study identifying allosteric PDK4 inhibitors with strong in vitro and in vivo activity, particularly compound 8c, which improved glucose tolerance and suppressed allergic and cancer-related processes. The findings highlight new molecular scaffolds for metabolic disease drug development and underscore the importance of precise kinase modulation in translational research.
Structure-Based Discovery of NSP15 Inhibitors in SARS-CoV-2
2026-07-09
This study presents a structure-based virtual screening approach to identify potent natural product inhibitors targeting NSP15, a key SARS-CoV-2 endoribonuclease involved in immune evasion. The findings reveal thymopentin and oleuropein as promising candidates, providing a framework for further antiviral drug development and illustrating the value of in silico strategies in rapid therapeutic discovery.
SERCA Inhibition by BHQ Enhances Hematopoietic Stem Cell Mob
2026-07-09
Li et al. (2025) reveal that selective SERCA inhibition with 2,5-di-tert-butylbenzene-1,4-diol (BHQ) induces mild endoplasmic reticulum stress, significantly facilitating hematopoietic stem cell (HSC) mobilization in vivo. The work uncovers a mechanistic role for the CaMKII-STAT3-CXCR4 pathway, suggesting new strategies for improving stem cell transplantation protocols.
Elobixibat Hydrate: Modulating Metabolism in T2DM-Related Co
2026-07-08
This single-arm pilot study investigates elobixibat hydrate, an ileal bile acid transporter inhibitor, for its metabolic and gastrointestinal effects in patients with type 2 diabetes mellitus (T2DM) and chronic constipation. The findings demonstrate significant reductions in HbA1c, LDL cholesterol, and arachidonic acid, highlighting the compound's dual role in metabolic modulation and symptom relief.
PPP1R3G/PP1γ-Mediated RIPK1 Activation Drives Cell Death Pat
2026-07-08
The reference study uncovers how PPP1R3G and PP1γ specifically dephosphorylate RIPK1 to promote its kinase activation, driving both apoptosis and necroptosis. This mechanistic insight redefines the regulation of RIPK1 in inflammation and programmed cell death, offering new opportunities for targeted modulation in cell biology and disease models.
Phenothiazines Boost Macrophage Antibacterial Response via R
2026-07-07
This study demonstrates that phenothiazines significantly enhance the antibacterial activity of macrophages by promoting reactive oxygen species (ROS) generation and autophagy. These findings provide mechanistic insight into host-directed therapeutic strategies for combating drug-resistant intracellular bacterial infections.
Nocodazole as a Microtubule Polymerization Inhibitor: Bridgi
2026-07-07
Explore how Nocodazole, a potent microtubule polymerization inhibitor, uniquely enables advanced DNA damage response studies by intersecting cytoskeletal dynamics and chromatin remodeling. This article unpacks mechanistic insights and assay design implications for cutting-edge cancer research.
Elobixibat Hydrate: Metabolic Modulation Beyond Constipation
2026-07-06
Explore the multifaceted role of Elobixibat hydrate as a selective ileal bile acid transporter inhibitor. This article uniquely examines its metabolic impact in type 2 diabetes mellitus and uncovers practical insights for advanced research applications.
ML133 HCl and the Future of Kir2.1 Channel Inhibition in PH
2026-07-06
This article explores the scientific and translational significance of ML133 HCl, a selective Kir2.1 potassium channel inhibitor, in the context of pulmonary hypertension and vascular remodeling. It integrates mechanistic detail, validated experimental evidence, and strategic guidance for researchers, positioning ML133 HCl as an indispensable tool for advanced studies of pulmonary artery smooth muscle cell (PASMC) proliferation and migration. The discussion bridges the gap between basic ion channel research and clinical translation, and offers a forward-looking perspective on the evolving landscape of cardiovascular and pulmonary therapeutics.
460 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page